Hims & Hers Health, Inc.
27.71USD
-1.4200 (-4.87%)
Fetching financial statements from SEC filings…
Not enough data yet
A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.
Sign in to share your take on HIMS.
| In $M except per-share | Q2 FY26 | Q1 FY26 | Q4 FY25* | Q3 FY25 | Q2 FY25 | Q1 FY25 | Q4 FY24* | Q3 FY24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 753 | 608 | 618 | 599 | 545 | 586 | 481 | 402 |
| Cost of Revenue | 272 | 211 | 173 | 157 | 129 | 155 | 112 | 84 |
| Gross Profit | 481 | 397 | 444 | 442 | 416 | 431 | 370 | 318 |
| Operating Income | -97 | -78 | 9 | 12 | 27 | 58 | 19 | 22 |
| Net Income | -86 | -92 | 21 | 16 | 43 | 49 | 26 | 76 |
| EPS (Diluted) | -$0.37 | -$0.40 | $0.08 | $0.06 | $0.17 | $0.20 | $0.10 | $0.32 |
* Derived period (computed from FY minus reported quarters). Source: SEC filings (EDGAR)